These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28655553)

  • 1. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management.
    Mattassi R; Manara E; Colombo PG; Manara S; Porcella A; Bruno G; Bruson A; Bertelli M
    J Vasc Surg; 2018 Mar; 67(3):922-932.e11. PubMed ID: 28655553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular anomalies: molecular bases, genetic testing and therapeutic approaches.
    Paolacci S; Zulian A; Bruson A; Manara E; Michelini S; Mattassi RE; Lee BB; Amato B; Bertelli M
    Int Angiol; 2019 Apr; 38(2):157-170. PubMed ID: 30938497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.
    Mori T; Hosomichi K; Chiga M; Mandai S; Nakaoka H; Sohara E; Okado T; Rai T; Sasaki S; Inoue I; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):63-75. PubMed ID: 26920127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability.
    Antoniadi T; Buxton C; Dennis G; Forrester N; Smith D; Lunt P; Burton-Jones S
    BMC Med Genet; 2015 Sep; 16():84. PubMed ID: 26392352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized diagnosis and management of congenital cataract by next-generation sequencing.
    Gillespie RL; O'Sullivan J; Ashworth J; Bhaskar S; Williams S; Biswas S; Kehdi E; Ramsden SC; Clayton-Smith J; Black GC; Lloyd IC
    Ophthalmology; 2014 Nov; 121(11):2124-37.e1-2. PubMed ID: 25148791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.
    Palmieri M; Di Sarno L; Tommasi A; Currò A; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Fallerini C; Arzini A; Pinto A; Vaghi M; Renieri A
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):740-744. PubMed ID: 32858245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.
    Kitamura Y; Kondo E; Urano M; Aoki R; Saito K
    J Hum Genet; 2016 Nov; 61(11):931-942. PubMed ID: 27357428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.
    Bastida JM; Del Rey M; Lozano ML; Sarasquete ME; Benito R; Fontecha ME; Fisac R; García-Frade LJ; Aguilar C; Martínez MP; Pardal E; Aguilera C; Pérez B; Ramos R; Cardesa MR; Martin-Antorán JM; Silvestre LA; Cebeira MJ; Bermejo N; Riesco S; Mendoza MC; García-Sanz R; González-Díaz M; Hernández-Rivas JM; González-Porras JR
    Haemophilia; 2016 Jul; 22(4):590-7. PubMed ID: 26879396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing.
    Weber S; Büscher AK; Hagmann H; Liebau MC; Heberle C; Ludwig M; Rath S; Alberer M; Beissert A; Zenker M; Hoyer PF; Konrad M; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jan; 31(1):73-81. PubMed ID: 26248470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing analysis in couples at increased risk for autosomal recessive disorders.
    Komlosi K; Diederich S; Fend-Guella DL; Bartsch O; Winter J; Zechner U; Beck M; Meyer P; Schweiger S
    Orphanet J Rare Dis; 2018 Jan; 13(1):23. PubMed ID: 29373990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic tests in lymphatic vascular malformations and lymphedema.
    Michelini S; Paolacci S; Manara E; Eretta C; Mattassi R; Lee BB; Bertelli M
    J Med Genet; 2018 Apr; 55(4):222-232. PubMed ID: 29440349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA.
    Revencu N; Eijkelenboom A; Bracquemart C; Alhopuro P; Armstrong J; Baselga E; Cesario C; Dentici ML; Eyries M; Frisk S; Karstensen HG; Gene-Olaciregui N; Kivirikko S; Lavarino C; Mero IL; Michiels R; Pisaneschi E; Schönewolf-Greulich B; Wieland I; Zenker M; Vikkula M
    Orphanet J Rare Dis; 2024 May; 19(1):213. PubMed ID: 38778413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive molecular and clinicopathological analysis of vascular malformations: A study of 319 cases.
    Ten Broek RW; Eijkelenboom A; van der Vleuten CJM; Kamping EJ; Kets M; Verhoeven BH; Grünberg K; Schultze Kool LJ; Tops BBJ; Ligtenberg MJL; Flucke U
    Genes Chromosomes Cancer; 2019 Aug; 58(8):541-550. PubMed ID: 30677207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling informs diagnoses and treatment in vascular anomalies.
    Li D; Sheppard SE; March ME; Battig MR; Surrey LF; Srinivasan AS; Matsuoka LS; Tian L; Wang F; Seiler C; Dayneka J; Borst AJ; Matos MC; Paulissen SM; Krishnamurthy G; Nriagu B; Sikder T; Casey M; Williams L; Rangu S; O'Connor N; Thomas A; Pinto E; Hou C; Nguyen K; Pellegrino da Silva R; Chehimi SN; Kao C; Biroc L; Britt AD; Queenan M; Reid JR; Napoli JA; Low DM; Vatsky S; Treat J; Smith CL; Cahill AM; Snyder KM; Adams DM; Dori Y; Hakonarson H
    Nat Med; 2023 Jun; 29(6):1530-1539. PubMed ID: 37264205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies.
    Ashton EJ; Legrand A; Benoit V; Roncelin I; Venisse A; Zennaro MC; Jeunemaitre X; Iancu D; Van't Hoff WG; Walsh SB; Godefroid N; Rotthier A; Del Favero J; Devuyst O; Schaefer F; Jenkins LA; Kleta R; Dahan K; Vargas-Poussou R; Bockenhauer D
    Kidney Int; 2018 Apr; 93(4):961-967. PubMed ID: 29398133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.
    Mallett AJ; McCarthy HJ; Ho G; Holman K; Farnsworth E; Patel C; Fletcher JT; Mallawaarachchi A; Quinlan C; Bennetts B; Alexander SI
    Kidney Int; 2017 Dec; 92(6):1493-1506. PubMed ID: 28844315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.